belapectin
Term · Oncology and biomedicine · MLC-T-ONC-011939
A carbohydrate-based galectin inhibitor, with potential antineoplastic activity. Belapectin binds to the carbohydrate-binding domain of galectins, especially galectin-3, and may result in an induction of apoptosis mediated through activation of both mitochondria and caspases. This may reduce tumor growth in galectin-overexpressing tumor cells. Galectins, often overexpressed on tumor cells, play a key role in cancer cell proliferation, apoptosis, tumor angiogenesis and evasion of immune responses.
| Identifier | MLC-T-ONC-011939 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | galactoarabino-rhamnogalacturonate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011939",
"term": "belapectin",
"field": "Oncology and biomedicine",
"definition": "A carbohydrate-based galectin inhibitor, with potential antineoplastic activity. Belapectin binds to the carbohydrate-binding domain of galectins, especially galectin-3, and may result in an induction of apoptosis mediated through activation of both mitochondria and caspases. This may reduce tumor growth in galectin-overexpressing tumor cells. Galectins, often overexpressed on tumor cells, play a key role in cancer cell proliferation, apoptosis, tumor angiogenesis and evasion of immune responses.",
"synonyms": [
"galactoarabino-rhamnogalacturonate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/belapectin/"
}
Record 3,401 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.